Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Inventory (2020 - 2025)

IceCure Medical (ICCM) has disclosed Inventory for 5 consecutive years, with $2.0 million as the latest value for Q4 2024.

  • On a quarterly basis, Inventory fell 12.62% to $2.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $2.0 million, a 12.62% decrease, with the full-year FY2024 number at $2.0 million, down 12.62% from a year prior.
  • Inventory was $2.0 million for Q4 2024 at IceCure Medical, down from $2.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $2.9 million in Q4 2022 to a low of $1.1 million in Q4 2020.
  • A 5-year average of $2.0 million and a median of $2.0 million in 2024 define the central range for Inventory.
  • Peak YoY movement for Inventory: surged 83.74% in 2021, then dropped 20.37% in 2023.
  • IceCure Medical's Inventory stood at $1.1 million in 2020, then soared by 83.74% to $2.0 million in 2021, then skyrocketed by 46.14% to $2.9 million in 2022, then decreased by 20.37% to $2.3 million in 2023, then decreased by 12.62% to $2.0 million in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Inventory are $2.0 million (Q4 2024), $2.3 million (Q4 2023), and $2.9 million (Q4 2022).